Increasing evidence suggests that Act A, in addition to activating the Act A/SMADs signaling pathway, simultaneously inhibits the JNK and p38 MAPK pathways, thereby reducing neuronal death after cerebral ischemia [18, 25]. This evidence concerns the gene SERPINA3 and brain ischemia.